<DOC>
	<DOCNO>NCT02169648</DOCNO>
	<brief_summary>The purpose study evaluate efficacy intravitreal ranibizumab determine pathogenesis macular edema , cause direct effect visual function . In particular , focus correlation treatment effectiveness ranibizumab role cytokine involve cause macular edema .</brief_summary>
	<brief_title>Development Intravitreal Ranibizumab Determining Pathogenesis Macular Edema With Retinal Vein Occlusion</brief_title>
	<detailed_description>Methodology : Aqueous humor sample ( 0.1ml ) obtain intravitreous injection ranibizumab measure level cytokine . Targeted cytokine follow ; IL-1 , IL-2 , IL-6 , IL-8 , IL-9 , IL-10 , IL-12 , IL-13 , IP-10 , MCP-1 , MMP-1 , MIP-1β , PDGF , VEGF , PlGF , ICAM-1 , TNF-α , RANTES , VEGFR-1 , VEGFR-2 , report expression level increase macular edema associate RVO . Cytokines measure multiple ELISA ( Luminex ) . Aqueous humor sample obtain manner patient recur first injection continuous monthly injection . Statistical analysis conduct examine difference cytokine level early late/incomplete responder ranibizumab , predict number injection stabilize cytokine level . Number center &amp; patient : Single center , 100 patient Sample size justification : Sample size calculation do , since study single-arm , observational study . Population : Inclusion criterion : patient RVO macular edema</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Retinal Vein Occlusion</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Foveal thickness &gt; 300 μm Best correct visual acuity &lt; 20/30 History retinal disease BRVO , glaucoma , uveitis , diabetes mellitus , rubeosis iridis , ocular infection , laser photocoagulation , intraocular surgery</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>macular edema</keyword>
	<keyword>branch retinal vein occlusion</keyword>
	<keyword>central retinal vein occlusion</keyword>
	<keyword>ranibizumab</keyword>
	<keyword>cytokine</keyword>
	<keyword>visual acuity</keyword>
	<keyword>central macular thickness</keyword>
</DOC>